Welcome to Informa Life Sciences
Our Business
Informa Life Sciences lead the market in providing quality, expert-led conferences; delivering the expert knowledge our clients need to excel in their professional roles and guaranteeing a competitive advantage for their organisations.
Our diverse portfolio covers the Pharmaceutical (Drug Discovery, Clinical Development, Regulatory Affairs, Biopharmaceutical, Generics and Business Strategy), Medical Devices and Diagnostics, Fine Chemicals and Agrochemicals and Veterinary Medicine arenas.
How We Work
We stay close to our markets, researching hand-in-hand with industry experts and maximising our unique position in the Informa family through first-hand input from the editorial teams of leading industry publications.
Our direct line to the industry enables us to identify and tap into the latest trends, creating programmes delivering high level analysis for industry and regulatory landscapes translated into the strategic advice and solutions for our delegates.
Quality Programmes and Expert Speakers
The panels of international, senior level industry practitioners we select provide the insightful and practical advice to address delegates’ most pressing challenges through unique presentations, case studies, panel discussions and lively debates. Equally, our conferences offer an invaluable networking space for face-to-face interaction with industry peers and thought-leaders where delegates can exchange ideas, advice and experiences and forge new contacts from across the globe.
Furthermore, the unrivalled calibre of our conference programmes, speakers and delegates attract top level, international organisations as sponsors and exhibitors needing to extend their reach and raise their profiles within a productive, business focused environment.
For full event listing, click here
…………………………………………………………………… |
Latest Event News
|
|
 Optimising Paediatric Drug Development
The new European legislation to increase and improve the development of paediatric drugs is now in place, but what has been the impact on the pharmaceutical industry? Knowing exactly what the regulators expect and how to implement the changes into your drug development has never been more crucial.
Paediatric drug development also faces unique challenges because children are not small adults. Significant pharmacokinetic, metabolical and toxocological differences in children of different ages pose a number of challenges to paediatric drug development. A proper understanding of the ethics and medical needs involved is also crucial, as well as technical feasibility studies and processes that are necessary for a proper pediatric drug development program
|
|
|
|
|
 Biobanking and Biorepositories
DNA/RNA sample collection, post-mortem sample collection, system interoperability, informed consent and ethical board reviews, these and many more topics will be discussed across Informa's four day Biobanking and Biorepositories conference. This NEW format for 2009 gives you the opportunity to tailor the conference to your needs. Select which days you want to attend and make the most out of your conference experience.
|
|
|
|
|
|
|